 | • レポートコード：GIR201101948 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、カルシトニン遺伝子関連ペプチド1型受容体の世界市場を調査対象にし、カルシトニン遺伝子関連ペプチド1型受容体の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（AFAP-3、AGN-241689、CGRP、エレヌマブ、その他）、用途別分析（心血管、代謝障害、歯痛み、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Allergan Plc、Vertex Pharmaceuticals Inc、Eli Lilly and Company、Amgen Inc、Teva Pharmaceutical Industries Ltd、Biohaven Pharmaceutical Holding Company Ltd、Merck & Co Inc、Fortress Biotech Inc ・メーカー別販売量、売上、市場シェア ・カルシトニン遺伝子関連ペプチド1型受容体の地域別市場分析 ・カルシトニン遺伝子関連ペプチド1型受容体の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・カルシトニン遺伝子関連ペプチド1型受容体のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・カルシトニン遺伝子関連ペプチド1型受容体のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・カルシトニン遺伝子関連ペプチド1型受容体の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・カルシトニン遺伝子関連ペプチド1型受容体の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・カルシトニン遺伝子関連ペプチド1型受容体の種類別市場規模2015-2020：AFAP-3、AGN-241689、CGRP、エレヌマブ、その他 ・カルシトニン遺伝子関連ペプチド1型受容体の用途別市場規模2015-2020：心血管、代謝障害、歯痛み、その他 ・カルシトニン遺伝子関連ペプチド1型受容体の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Calcitonin Gene Related Peptide Type 1 Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Calcitonin Gene Related Peptide Type 1 Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Calcitonin Gene Related Peptide Type 1 Receptor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Calcitonin Gene Related Peptide Type 1 Receptor market has been segmented into
AFAP-3
AGN-241689
CGRP
Erenumab
Others
By Application, Calcitonin Gene Related Peptide Type 1 Receptor has been segmented into:
Cardiovascular
Metabolic Disorders
Dental Pain
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Calcitonin Gene Related Peptide Type 1 Receptor market presented in the report. This section sheds light on the sales growth of different regional and country-level Calcitonin Gene Related Peptide Type 1 Receptor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Calcitonin Gene Related Peptide Type 1 Receptor market.
The report offers in-depth assessment of the growth and other aspects of the Calcitonin Gene Related Peptide Type 1 Receptor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Calcitonin Gene Related Peptide Type 1 Receptor Market Share Analysis
Calcitonin Gene Related Peptide Type 1 Receptor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Calcitonin Gene Related Peptide Type 1 Receptor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Calcitonin Gene Related Peptide Type 1 Receptor sales, revenue and market share for each player covered in this report.
The major players covered in Calcitonin Gene Related Peptide Type 1 Receptor are:
Allergan Plc
Vertex Pharmaceuticals Inc
Eli Lilly and Company
Amgen Inc
Teva Pharmaceutical Industries Ltd
Biohaven Pharmaceutical Holding Company Ltd
Merck & Co Inc
Fortress Biotech Inc
Among other players domestic and global, Calcitonin Gene Related Peptide Type 1 Receptor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Calcitonin Gene Related Peptide Type 1 Receptor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Calcitonin Gene Related Peptide Type 1 Receptor, with price, sales, revenue and global market share of Calcitonin Gene Related Peptide Type 1 Receptor in 2018 and 2019.
Chapter 3, the Calcitonin Gene Related Peptide Type 1 Receptor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Calcitonin Gene Related Peptide Type 1 Receptor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Calcitonin Gene Related Peptide Type 1 Receptor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Calcitonin Gene Related Peptide Type 1 Receptor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Calcitonin Gene Related Peptide Type 1 Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 AFAP-3
1.2.3 AGN-241689
1.2.4 CGRP
1.2.5 Erenumab
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cardiovascular
1.3.3 Metabolic Disorders
1.3.4 Dental Pain
1.3.5 Others
1.4 Overview of Global Calcitonin Gene Related Peptide Type 1 Receptor Market
1.4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan Plc
2.1.1 Allergan Plc Details
2.1.2 Allergan Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan Plc SWOT Analysis
2.1.4 Allergan Plc Product and Services
2.1.5 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Vertex Pharmaceuticals Inc
2.2.1 Vertex Pharmaceuticals Inc Details
2.2.2 Vertex Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Vertex Pharmaceuticals Inc SWOT Analysis
2.2.4 Vertex Pharmaceuticals Inc Product and Services
2.2.5 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly and Company
2.3.1 Eli Lilly and Company Details
2.3.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly and Company SWOT Analysis
2.3.4 Eli Lilly and Company Product and Services
2.3.5 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen Inc
2.4.1 Amgen Inc Details
2.4.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen Inc SWOT Analysis
2.4.4 Amgen Inc Product and Services
2.4.5 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva Pharmaceutical Industries Ltd
2.5.1 Teva Pharmaceutical Industries Ltd Details
2.5.2 Teva Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva Pharmaceutical Industries Ltd SWOT Analysis
2.5.4 Teva Pharmaceutical Industries Ltd Product and Services
2.5.5 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biohaven Pharmaceutical Holding Company Ltd
2.6.1 Biohaven Pharmaceutical Holding Company Ltd Details
2.6.2 Biohaven Pharmaceutical Holding Company Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biohaven Pharmaceutical Holding Company Ltd SWOT Analysis
2.6.4 Biohaven Pharmaceutical Holding Company Ltd Product and Services
2.6.5 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck & Co Inc
2.7.1 Merck & Co Inc Details
2.7.2 Merck & Co Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck & Co Inc SWOT Analysis
2.7.4 Merck & Co Inc Product and Services
2.7.5 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fortress Biotech Inc
2.8.1 Fortress Biotech Inc Details
2.8.2 Fortress Biotech Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Fortress Biotech Inc SWOT Analysis
2.8.4 Fortress Biotech Inc Product and Services
2.8.5 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturer Market Share in 2019
3.3.2 Top 6 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Market Share by Regions
4.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Market Share by Regions (2015-2020)
4.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
4.3 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
4.5 South America Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Market Share by Country
5.1.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Country (2015-2020)
5.1.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Market Share by Country (2015-2020)
5.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
5.3 Canada Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
5.4 Mexico Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Market Share by Country
6.1.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Market Share by Country (2015-2020)
6.2 Germany Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
6.3 UK Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
6.4 France Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
6.5 Russia Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
6.6 Italy Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Market Share by Regions (2015-2020)
7.2 China Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
7.3 Japan Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
7.4 Korea Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
7.5 India Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
7.7 Australia Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Market Share by Country
8.1.1 South America Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Country (2015-2020)
8.1.2 South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
8.3 Argentina Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
9.3 Turkey Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
9.4 Egypt Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
9.5 South Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales and Market Share by Type (2015-2020)
10.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Market Share by Type (2015-2020)
10.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2015-2020)
11 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Segment by Application
11.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2015-2020)
11.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Application (2015-2020)
11.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Growth Rate (2021-2025)
12.2 Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast by Regions (2021-2025)
12.2.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast (2021-2025)
12.2.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast (2021-2025)
12.2.4 South America Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast (2021-2025)
12.3 Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast by Type (2021-2025)
12.3.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Type (2021-2025)
12.3.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share Forecast by Type (2021-2025)
12.4 Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast by Application (2021-2025)
12.4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Application (2021-2025)
12.4.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Calcitonin Gene Related Peptide Type 1 Receptor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Allergan Plc Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Major Business
Table 9. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 10. Allergan Plc SWOT Analysis
Table 11. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 12. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Vertex Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 14. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Major Business
Table 15. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 16. Vertex Pharmaceuticals Inc SWOT Analysis
Table 17. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 18. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Major Business
Table 21. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 22. Eli Lilly and Company SWOT Analysis
Table 23. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 24. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 26. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Major Business
Table 27. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 28. Amgen Inc SWOT Analysis
Table 29. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 30. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Major Business
Table 33. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 34. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 35. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 36. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biohaven Pharmaceutical Holding Company Ltd Basic Information, Manufacturing Base and Competitors
Table 38. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Major Business
Table 39. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 40. Biohaven Pharmaceutical Holding Company Ltd SWOT Analysis
Table 41. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 42. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 44. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Major Business
Table 45. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 46. Merck & Co Inc SWOT Analysis
Table 47. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 48. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Fortress Biotech Inc Basic Information, Manufacturing Base and Competitors
Table 50. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Major Business
Table 51. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 52. Fortress Biotech Inc SWOT Analysis
Table 53. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Services
Table 54. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Manufacturer (2018-2019) (K Pcs)
Table 56. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Regions (2015-2020) (K Pcs)
Table 58. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Regions (2015-2020)
Table 59. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 61. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Countries (2015-2020)
Table 62. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 64. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 65. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Countries (2015-2020)
Table 66. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Regions (2015-2020) (K Pcs)
Table 68. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 71. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Countries (2015-2020)
Table 72. South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 75. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 78. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 79. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Type (2015-2020)
Table 80. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type (2015-2020) (USD Million)
Table 81. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Type (2015-2020)
Table 82. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 83. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Application (2015-2020)
Table 84. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Regions (2021-2025) (K Pcs)
Table 85. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share Forecast by Regions (2021-2025)
Table 86. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Type (2021-2025) (K Pcs)
Table 87. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share Forecast by Type (2021-2025)
Table 88. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Application (2021-2025)
Table 89. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Calcitonin Gene Related Peptide Type 1 Receptor Picture
Figure 2. Global Sales Market Share of Calcitonin Gene Related Peptide Type 1 Receptor by Type in 2019
Figure 3. AFAP-3 Picture
Figure 4. AGN-241689 Picture
Figure 5. CGRP Picture
Figure 6. Erenumab Picture
Figure 7. Others Picture
Figure 8. Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application in 2018
Figure 9. Cardiovascular Picture
Figure 10. Metabolic Disorders Picture
Figure 11. Dental Pain Picture
Figure 12. Others Picture
Figure 13. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Calcitonin Gene Related Peptide Type 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Manufacturer in 2019
Figure 34. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Regions (2015-2020)
Figure 41. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Regions in 2018
Figure 42. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
Figure 43. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
Figure 45. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020)
Figure 47. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Countries (2015-2020)
Figure 49. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Countries in 2018
Figure 50. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Countries in 2018
Figure 52. United States Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Countries in 2019
Figure 58. Germany Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Regions 2019
Figure 66. China Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Countries in 2019
Figure 73. South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Countries in 2019
Figure 74. Brazil Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
N-ホルミルペプチド受容体2の世界市場 2020年 Market Overview The global N-Formyl Peptide Receptor 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The N-Formyl Peptide …- グルカゴン様ペプチド2受容体の世界市場 2020年 Market Overview The global Glucagon Like Peptide 2 Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glucagon Lik…
- ペプチドベース代謝障害治療薬の世界市場 2020年 Market Overview The global Peptide Based Metabolic Disorders Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Th…
- ペプチドベース心血管治療薬の世界市場 2020年 Market Overview The global Peptide Based Cardiovascular Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pep…
- グルカゴン様ペプチド-2（GLP-2）アゴニストの世界市場 2020年 Market Overview The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gluca…